Pitcairn’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $669K | Sell |
2,132
-252
| -11% | -$79.1K | 0.04% | 337 |
|
|
2025
Q1 | $726K | Sell |
2,384
-9
| -0.4% | -$2.74K | 0.04% | 333 |
|
|
2024
Q4 | $795K | Sell |
2,393
-43
| -2% | -$14.3K | 0.05% | 301 |
|
|
2024
Q3 | $813K | Sell |
2,436
-342
| -12% | -$114K | 0.05% | 305 |
|
|
2024
Q2 | $1.14M | Buy |
2,778
+67
| +2% | +$27.6K | 0.07% | 249 |
|
|
2024
Q1 | $1.1M | Sell |
2,711
-233
| -8% | -$94.2K | 0.07% | 254 |
|
|
2023
Q4 | $902K | Sell |
2,944
-91
| -3% | -$27.9K | 0.07% | 258 |
|
|
2023
Q3 | $735K | Sell |
3,035
-462
| -13% | -$112K | 0.06% | 268 |
|
|
2023
Q2 | $840K | Sell |
3,497
-95
| -3% | -$22.8K | 0.07% | 237 |
|
|
2023
Q1 | $675K | Sell |
3,592
-590
| -14% | -$111K | 0.06% | 274 |
|
|
2022
Q4 | $888K | Sell |
4,182
-238
| -5% | -$50.6K | 0.09% | 197 |
|
|
2022
Q3 | $695K | Buy |
4,420
+65
| +1% | +$10.2K | 0.08% | 229 |
|
|
2022
Q2 | $652K | Buy |
4,355
+250
| +6% | +$37.4K | 0.07% | 242 |
|
|
2022
Q1 | $672K | Sell |
4,105
-89
| -2% | -$14.6K | 0.06% | 279 |
|
|
2021
Q4 | $913K | Sell |
4,194
-1,377
| -25% | -$300K | 0.06% | 227 |
|
|
2021
Q3 | $1.06M | Sell |
5,571
-24
| -0.4% | -$4.55K | 0.07% | 193 |
|
|
2021
Q2 | $988K | Sell |
5,595
-205
| -4% | -$36.2K | 0.07% | 205 |
|
|
2021
Q1 | $951K | Sell |
5,800
-1,613
| -22% | -$264K | 0.07% | 202 |
|
|
2020
Q4 | $1.03M | Sell |
7,413
-23
| -0.3% | -$3.2K | 0.08% | 171 |
|
|
2020
Q3 | $831K | Buy |
7,436
+273
| +4% | +$30.5K | 0.07% | 178 |
|
|
2020
Q2 | $666K | Sell |
7,163
-555
| -7% | -$51.6K | 0.06% | 189 |
|
|
2020
Q1 | $566K | Buy |
7,718
+3,894
| +102% | +$286K | 0.07% | 183 |
|
|
2019
Q4 | $321K | Buy |
3,824
+1,004
| +36% | +$84.3K | 0.03% | 372 |
|
|
2019
Q3 | $237K | Buy |
+2,820
| New | +$237K | 0.02% | 467 |
|